A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

April 26, 2023

Study Completion Date

April 26, 2023

Conditions
Lymphoma, Non-Hodgkin
Interventions
DRUG

TAK-981

TAK-981 intravenous infusion.

DRUG

Rituximab

Rituximab intravenous infusion.

Trial Locations (59)

10126

Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Turin

12203

Charite - Universitatsmedizin Berlin, Berlin

13273

Institut Paoli Calmettes, Marseille

15224

Western Pennsylvania Hospital, Pittsburgh

20122

Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan

20133

Istituto Nazionale Dei Tumori, Milan

20162

ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda, Milan

21000

Hopital Francois Mitterand, Dijon

27100

Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia

27514

Levine Cancer Institute - Charlotte, Chapel Hill

27834

East Carolina University, Greenville

28034

Hospital Universitario Ramon y Cajal, Madrid

28046

Hospital Universitario La Paz - PPDS, Madrid

28100

A.O.U. Maggiore della Carita, Novara

34090

CHU Montpellier - Hopital St Eloi, Montpellier

35000

Hopital Prive Sevigne, Rennes

35294

University of Alabama at Birmingham, Birmingham

37007

Complejo Asistencial Universitario de Salamanca H. Clinico, Salamanca

39120

Otto-von-Guericke-Universitat Magdeburg, Magdeburg

41013

Hospital Universitario Virgen del Rocio - PPDS, Seville

43210

Ohio State University Wexner Medical Center, Columbus

44093

Hotel Dieu - Nantes, Nantes

44106

University Hospitals Cleveland Medical Center, Cleveland

45147

Universitatsklinikum Essen, Essen

45219

University of Cincinnati, Cincinnati

48100

Azienda Sanitaria Locale di Ravenna, Ravenna

48109

University of Michigan Comprehensive Cancer Center, Ann Arbor

55905

Mayo Clinic - Cancer Center - Rochester - PPDS, Rochester

72076

Universitatsklinikum Tubingen, Tübingen

73039

Azienda Ospedaliera Cardinale G Panico, Tricase

75012

Hopital Saint Antoine, Paris

75013

Hopital Universitaire Pitie Salpetriere, Paris

75230

Texas Oncology (Medical City) - USOR, Dallas

75702

Texas Oncology (Tyler) - USOR, Tyler

76038

Centre Henri Becquerel, Rouen

79106

Universitatsklinikum Freiburg, Freiburg im Breisgau

81675

Klinikum rechts der Isa der Technischen Universitaet Muenchen, München

97080

Universitatsklinikum Wurzburg, Würzburg

97239

City of Hope - Comprehensive Cancer Center (CCC), Portland

100142

Beijing Cancer Hospital, Beijing

200123

Shanghai East Hospital, Shanghai

H2L 4M1

Centre Hospitalier de l'Universite de Montreal, Montreal

H9R 4S3

Sir Mortimer B Davis Jewish General Hospital, Pointe-Claire

04103

Universitatsklinikum Leipzig, Leipzig

00152

Azienda Ospedaliera San Camillo Forlanini, Rome

460-0001

National Hospital Organization Nagoya Medical Center, Nagoya

277-8577

National Cancer Center Hospital East, Kashiwa

980-0872

National University Corporation Tohoku University Tohoku University Hospital, Sendai

589-0014

Kindai University Hospital, Osakasayama-Shi

135-0063

The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Koto-Ku

'08036

Hospital Clinic de Barcelona, Barcelona

08003

Hospital del Mar, Barcelona

08041

Hospital de La Santa Creu i Sant Pau, Barcelona

PL6 8DH

Derriford Hospital, Plymouth

G12 0YN

Beatson West of Scotland Cancer Centre - PPDS, Glasgow

NW1 2PG

University College London, London

SW7 3RP

Royal Marsden Hospital - Downs Road, London

OX3 7LE

Oxford University Hospitals NHS Trust, Oxford

B15 2TH

University Hospital Birmingham, Birmingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY